Maxwell John T. 4
4 · Aquestive Therapeutics, Inc. · Filed Mar 4, 2019
Insider Transaction Report
Form 4
Maxwell John T.
SVP-Chief Financial Officer
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2019-02-28+95,000→ 95,000 totalExercise: $8.05Exp: 2029-02-28→ Common Stock (95,000 underlying)
Footnotes (1)
- [F1]The units subject to the Award shall vest 25% 1st year, 25% 2nd year and 50% 3rd year on the commencement anniversaries.